In 2024, the Business Enterprise R&D expenditure in human health activities in Italy is forecasted at 453.39 million USD PPP. Growth is projected to continue steadily with an annual increase of approximately 4.9% resulting in expected expenditures of 541.47 million USD PPP by 2028. This consistent rise indicates a positive momentum from previous years where 2023 marked a notable baseline.
Future trends to watch include:
- Increased investment in digital health technologies to enhance healthcare delivery.
- Greater collaboration between private enterprises and public institutions to boost innovation.
- Potential impacts of regulatory changes and economic conditions on future R&D commitments.
